Last reviewed · How we verify
DXC006
At a glance
| Generic name | DXC006 |
|---|---|
| Also known as | Recombinant Humanized Antibody-drug conjugate |
| Sponsor | Hangzhou DAC Biotechnology Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DXC006 CI brief — competitive landscape report
- DXC006 updates RSS · CI watch RSS
- Hangzhou DAC Biotechnology Co., Ltd. portfolio CI